Alessandro Cecchi

2.2k total citations · 1 hit paper
27 papers, 1.9k citations indexed

About

Alessandro Cecchi is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Alessandro Cecchi has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Alessandro Cecchi's work include Enzyme function and inhibition (25 papers), Synthesis and Catalytic Reactions (19 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Alessandro Cecchi is often cited by papers focused on Enzyme function and inhibition (25 papers), Synthesis and Catalytic Reactions (19 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Alessandro Cecchi collaborates with scholars based in Italy, France and Slovakia. Alessandro Cecchi's co-authors include Claudiu T. Supuran, Andrea Scozzafava, Alžbeta Hulı́ková, Silvia Pastoreková, Claudia Temperini, Jean‐Yves Winum, Angela Casini, Eliška Švastová, Jaromı́r Pastorek and Miriam Zaťovičová and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Physical Chemistry B and FEBS Letters.

In The Last Decade

Alessandro Cecchi

27 papers receiving 1.8k citations

Hit Papers

Hypoxia activates the capacity of tumor‐associated carbon... 2004 2026 2011 2018 2004 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandro Cecchi Italy 19 1.6k 1.1k 503 354 208 27 1.9k
Anne Thiry Belgium 12 1.0k 0.6× 733 0.7× 250 0.5× 299 0.8× 128 0.6× 15 1.2k
Vincenzo Alterio Italy 27 3.3k 2.0× 2.3k 2.1× 852 1.7× 1.1k 3.2× 103 0.5× 52 3.6k
Marc Nazaré Germany 27 845 0.5× 798 0.8× 235 0.5× 104 0.3× 59 0.3× 102 2.1k
Paul W. Baures United States 20 659 0.4× 586 0.6× 154 0.3× 69 0.2× 72 0.3× 55 1.3k
Francesco Mincione Italy 23 1.7k 1.0× 1.4k 1.3× 448 0.9× 639 1.8× 24 0.1× 37 2.1k
Steven E. Hall United States 20 952 0.6× 574 0.5× 65 0.1× 139 0.4× 69 0.3× 40 1.5k
Chingkuang Tu United States 18 604 0.4× 255 0.2× 146 0.3× 102 0.3× 39 0.2× 29 900
Ana Ramos Spain 24 1.1k 0.6× 1.1k 1.0× 49 0.1× 185 0.5× 255 1.2× 70 2.1k
F. G. West Canada 43 861 0.5× 4.0k 3.8× 77 0.2× 134 0.4× 127 0.6× 175 4.7k
Makhluf J. Haddadin Lebanon 25 517 0.3× 1.7k 1.6× 108 0.2× 78 0.2× 54 0.3× 129 2.1k

Countries citing papers authored by Alessandro Cecchi

Since Specialization
Citations

This map shows the geographic impact of Alessandro Cecchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Cecchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Cecchi more than expected).

Fields of papers citing papers by Alessandro Cecchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Cecchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Cecchi. The network helps show where Alessandro Cecchi may publish in the future.

Co-authorship network of co-authors of Alessandro Cecchi

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Cecchi. A scholar is included among the top collaborators of Alessandro Cecchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Cecchi. Alessandro Cecchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Winum, Jean‐Yves, Fabrizio Carta, Carol Ward, et al.. (2012). Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines. Bioorganic & Medicinal Chemistry Letters. 22(14). 4681–4685. 55 indexed citations
2.
Mincione, Francesco, Francesca Benedini, Stefano Biondi, et al.. (2011). Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action. Bioorganic & Medicinal Chemistry Letters. 21(11). 3216–3221. 37 indexed citations
3.
Benedini, Francesca, Stefano Biondi, Francesco Impagnatiello, et al.. (2009). Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma. Bioorganic & Medicinal Chemistry Letters. 19(23). 6565–6570. 55 indexed citations
4.
Ciani, Laura, Alessandro Cecchi, Claudia Temperini, Claudiu T. Supuran, & Sandra Ristori. (2009). Dissecting the Inhibition Mechanism of Cytosolic versus Transmembrane Carbonic Anhydrases by ESR. The Journal of Physical Chemistry B. 113(42). 13998–14005. 11 indexed citations
5.
Temperini, Claudia, Alessandro Cecchi, Andrea Scozzafava, & Claudiu T. Supuran. (2008). Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited—old leads for new applications?. Organic & Biomolecular Chemistry. 6(14). 2499–2499. 82 indexed citations
6.
Cecchi, Alessandro, Laura Ciani, Jean‐Yves Winum, et al.. (2008). Carbonic anhydrase inhibitors: Design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes. Bioorganic & Medicinal Chemistry Letters. 18(12). 3475–3480. 15 indexed citations
7.
Cecchi, Alessandro & Claudiu T. Supuran. (2008). Fluorescence- and Spin-Labeled Carbonic Anhydrase Inhibitors. Current Pharmaceutical Design. 14(7). 699–707. 10 indexed citations
8.
Temperini, Claudia, Alessandro Cecchi, Andrea Scozzafava, & Claudiu T. Supuran. (2008). Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference. Bioorganic & Medicinal Chemistry. 17(3). 1214–1221. 54 indexed citations
9.
10.
Nishimori, Isao, Tomoko Minakuchi, Saburo Onishi, et al.. (2008). Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. Journal of Enzyme Inhibition and Medicinal Chemistry. 24(1). 70–76. 31 indexed citations
11.
Thiry, Anne, Alessandro Cecchi, Raphaël Frédérick, et al.. (2008). Ligand-based and structure-based virtual screening to identify carbonic anhydrase IX inhibitors. Bioorganic & Medicinal Chemistry. 17(2). 553–557. 9 indexed citations
12.
Temperini, Claudia, Alessandro Cecchi, Andrea Scozzafava, & Claudiu T. Supuran. (2008). Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide–isozyme II adduct. Bioorganic & Medicinal Chemistry Letters. 18(8). 2567–2573. 64 indexed citations
13.
Temperini, Claudia, Alessandro Cecchi, Andrea Scozzafava, & Claudiu T. Supuran. (2008). Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference. Journal of Medicinal Chemistry. 52(2). 322–328. 54 indexed citations
14.
Nishimori, Isao, Tomoko Minakuchi, Saburo Onishi, et al.. (2007). Carbonic anhydrase inhibitors: Cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. Bioorganic & Medicinal Chemistry. 15(23). 7229–7236. 96 indexed citations
15.
Cecchi, Alessandro, et al.. (2007). Competing kinetic pathways in the bromine addition to allylic ethers in 1,2‐dichloroethane: Opposite temperature effects. International Journal of Chemical Kinetics. 39(4). 197–203. 2 indexed citations
16.
Winum, Jean‐Yves, et al.. (2006). Carbonic anhydrase inhibitors. N-Cyanomethylsulfonamides—a new zinc binding group in the design of inhibitors targeting cytosolic and membrane-anchored isoforms. Journal of Enzyme Inhibition and Medicinal Chemistry. 21(4). 477–481. 3 indexed citations
17.
Cecchi, Alessandro, Scott D. Taylor, Yong Liu, et al.. (2005). Carbonic anhydrase inhibitors: Inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Bioorganic & Medicinal Chemistry Letters. 15(23). 5192–5196. 20 indexed citations
18.
Cecchi, Alessandro, Alžbeta Hulı́ková, Silvia Pastoreková, et al.. (2005). Carbonic Anhydrase Inhibitors. Design of Fluorescent Sulfonamides as Probes of Tumor-Associated Carbonic Anhydrase IX That Inhibit Isozyme IX-Mediated Acidification of Hypoxic Tumors. Journal of Medicinal Chemistry. 48(15). 4834–4841. 181 indexed citations
19.
Švastová, Eliška, Alžbeta Hulı́ková, Miriam Zaťovičová, et al.. (2004). Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pH. FEBS Letters. 577(3). 439–445. 610 indexed citations breakdown →
20.
Cecchi, Alessandro, Jean‐Yves Winum, Alessio Innocenti, et al.. (2004). Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. Bioorganic & Medicinal Chemistry Letters. 14(23). 5775–5780. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026